Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Esperoct
Descriptions
Antihemophilic factor (recombinant), glycopegylated-exei injection is used to treat and control bleeding in patients with hemophilia A (congenital Factor VIII deficiency). It is also used to reduce the number of bleeding episodes in patients when used regularly. Antihemophilic factor (recombinant), glycopegylated-exei injection is also used to prevent bleeding during a surgical procedure.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2022
Copyright © 2022 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.